First Time Loading...

Chemomab Therapeutics Ltd
NASDAQ:CMMB

Watchlist Manager
Chemomab Therapeutics Ltd Logo
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Watchlist
Price: 0.87 USD -0.23% Market Closed
Updated: May 18, 2024

Cash Flow Statement

Cash Flow Statement
Chemomab Therapeutics Ltd

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Operating Cash Flow
Net Income
(27)
(19)
(16)
(10)
(6)
(6)
(8)
(9)
(12)
(16)
(19)
(24)
(28)
(31)
(33)
(29)
(24)
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Non-Cash Items
6
1
0
0
0
0
1
1
2
3
4
5
4
4
3
2
1
Cash Taxes Paid
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
Change in Working Capital
5
3
3
(0)
0
1
(3)
(3)
(2)
(2)
1
2
3
4
4
1
(0)
Cash from Operating Activities
(16)
N/A
(15)
+7%
(12)
+20%
(10)
+21%
(5)
+45%
(5)
+12%
(9)
-102%
(11)
-18%
(12)
-12%
(15)
-20%
(15)
-1%
(18)
-18%
(20)
-16%
(24)
-17%
(26)
-7%
(26)
+0%
(24)
+8%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Items
0
0
(0)
(0)
(0)
(0)
(21)
(26)
(45)
(43)
(20)
(9)
20
32
26
24
16
Cash from Investing Activities
(0)
N/A
(0)
+70%
(0)
-67%
0
N/A
(0)
N/A
(0)
+17%
(21)
-41 160%
(26)
-24%
(45)
-76%
(43)
+5%
(20)
+52%
(9)
+54%
20
N/A
32
+62%
26
-19%
24
-8%
16
-32%
Financing Cash Flow
Net Issuance of Common Stock
31
0
3
4
4
49
44
43
59
13
15
15
0
0
2
2
4
Other
(4)
(1)
1
1
1
3
18
18
2
0
(15)
(15)
(1)
(1)
0
0
0
Cash from Financing Activities
27
N/A
(1)
N/A
4
N/A
4
+15%
5
+13%
52
+996%
62
+20%
62
-1%
61
-1%
13
-78%
(0)
N/A
(0)
+79%
(1)
-2 600%
(1)
N/A
1
N/A
1
-7%
4
+599%
Change in Cash
Net Change in Cash
10
N/A
(16)
N/A
(9)
+46%
(5)
+39%
(1)
+89%
47
N/A
32
-32%
25
-23%
4
-86%
(44)
N/A
(35)
+20%
(27)
+24%
(2)
+94%
7
N/A
0
-93%
(2)
N/A
(4)
-166%
Free Cash Flow
Free Cash Flow
(17)
N/A
(15)
+8%
(12)
+20%
(9)
+23%
(5)
+44%
(5)
+12%
(9)
-104%
(11)
-18%
(13)
-13%
(15)
-19%
(15)
N/A
(18)
-18%
(20)
-15%
(24)
-17%
(26)
-7%
(26)
+0%
(24)
+8%

See Also

Discover More